首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
POLYPRENYL COMPOUNDS, PROCESSES FOR PREPARING THEM, AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
摘要
申请公布号
EP0194693(B1)
申请公布日期
1989.07.26
申请号
EP19860103426
申请日期
1986.03.14
申请人
EISAI CO., LTD.
发明人
NAKAMOTO. KOUJI;SUZUKI, TAKESHI;ABE, SHINYA;HAYASHI, KENJI;KAJIWARA, AKIHARU;YAMATSU, ISAO;OTSUKA, ISSEI;SHIOJIRI, HIROYUKI
分类号
A61K31/16;A61K31/165;A61K31/19;A61P3/06;A61P9/10;C07C51/00;C07C57/30;C07C57/42;C07C61/39;C07C63/04;C07C67/00;C07C233/17;C07C233/23;C07C233/69;C07C237/22;C07C237/08;C07C237/20
主分类号
A61K31/16
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Production method of light housing frame to be structured with a reflection panel and embossed transparent cover panel for the reduction of brightness and the improvement of illumination of a LED lighting
PROTON PUMP INHIBITOR FORMULATIONS, AND METHODS OF PREPARING AND USING SUCH FORMULATIONS
ADAPTIVE HYBRIDTRANSFORMATION FÜR DIE SIGNALANALYSE UND SYNTHESE
VERFAHREN UND VORRICHTUNG ZUR KODIERUNG VON VIDEODATEN SOWIE VERFAHREN UND VORRICHTUNG ZUR DEKODIERUNG VON VIDEODATEN
HIGH FREQUENCY ULTRASOUND IMAGING BY ROTATIONAL SCANNING OF ANGLED TRANSDUCERS
PRESSURE-SENSITIVE ADHESIVE LABELS
CONSTUCTION OF TARGETED ADAPTIVE DESIGNS AND ESTIMATOR LEARNING FOR ADAPTIVE DESIGNS
OPTICAL RECEIVER WITH TWO PHOTONIC IC
HETEROCYCLIC COMPOUNDS AND COMPOSITIONS AS C-KIT AND PDGFR KINASE INHIBITORS
TRANSCUTANEOUS OSSEOINTEGRATED DEVICE FOR PROSTHESES
METHODS FOR USING RAPAMYCIN ANALOGUES IN THE TREATMENT OF NEUROLOGICAL DISORDERS
MEDICAL FLUID MACHINE HAVING SOLENOID CONTROL SYSTEM WITH TEMPERATURE COMPENSATION
METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
MODULATORS OF THE HISTAMINE H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
MOUNTABLE CIRCUIT BREAKER
ADJUSTABLE ELECTRICAL PROBES FOR CIRCUIT BREAKER TESTER
MODULAR DEVICE FOR ELECTRICAL POWER DISTRIBUTION
CLEANING CONCENTRATE SUPPLY DEVICE, AND MILKING DEVICE AND METHOD THEREWITH
TARGET MEMBER
BRCA1 mRNA EXPRESSION LEVELS PREDICT SURVIVAL IN BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY